Guardant Health, Inc. ã¯ã粟å¯è
«çåŠã®äŒæ¥ã§ãããç±³åœããã³åœéçã«è¡æ¶²æ€æ»ãããŒã¿ã»ãããåæãæäŸããŠããŸããå瀟ã¯ãé²è¡æããã«å¯Ÿãã Guardant360ãGuardant360 CDxãGuardantOMNI æ¶²äœçæ€ããŒã¹ã®æ€æ»ãããã³é²è¡ããæ£è
ã®èšåºã²ãã æ¶²äœçæ€ããŒã¿ã»ãããå«ã in-silico ç ç©¶ãã©ãããã©ãŒã GuardantINFORM ãæäŸããŠããŸãããŸããæ©æããæ£è
ã®è¡åããã³è¡åŸæ²»çéžæã®ããã® LUNAR ããã°ã©ã ããã®æ€æ»ãããã¹ã¯ãªãŒãã³ã°ã®å¯Ÿè±¡ãšãªãç¡çç¶ã®å人ã®ããã®æ©ææ€åºã®ããã® LUNAR-2 æ€æ»ãããã³ Guardant360 ã¢ãã»ã€ã§æ€æ»ããå®çšçãªå€åãã¿ãããæ£è
ãæœåšçã«é¢é£æ§ã®ããèšåºè©Šéšã«çµã³ä»ããããšãæ±ããèšåºããã³ãã€ãªå»è¬å顧客åãã®çµ±åãœãããŠã§ã¢ããŒã¹ã®ãœãªã¥ãŒã·ã§ã³ GuardantConnect ãéçºããŠããŸããããã«ãåç€Ÿã¯æ®åç
å€ããã³åçºã¢ãã¿ãªã³ã°çšã® Guardant Reveal TestãGuardant360 çµç¹éºäŒååå€å®è£œåGuardant Health, Inc.ã¯ãæ°åã³ãããŠã€ã«ã¹ã®æ€åºã«äœ¿çšããããã®ãã³ã³ãããªã³èšºæè¬ã®éçºãšèŠå¶åœå±ã®æ¿èªãèšåºè©Šéšã®ç޹ä»ããªããããã€ãªãã·ãŒæ€æ»ã®éçºãšãµããŒããµãŒãã¹ãªã©ã®éçºãµãŒãã¹ããã€ãªå»è¬åäŒæ¥ãå»çæ©é¢ã«æäŸããŠããŸããGuardant Health, Inc.ã¯ã第äžäžå
±ãšææºããŠãé²è¡æ§è»¢ç§»æ§éå°çްèèºããã«ãããEnhertuã®ã³ã³ãããªã³èšºæè¬ãšããŠGuardant360 CDxãéçºããŠããŸããKinnate Biopharma Inc.ãšã¯ãBRAFã¯ã©ã¹IãIIãIIIã®å€ç°ã䌎ãé²è¡æ§åºåœ¢è
«çã®æ£è
ã®æç
çã®ç¹åŸŽä»ãã«çŠç¹ãåœãŠãŠããŸãããŸããThe Royal Marsden NHS Foundation Trustãšã¯ã瀟å
ã®ãªããããã€ãªãã·ãŒæ€æ»ãµãŒãã¹ã確ç«ããããã«ææºããŠããŸããGuardant Health, Inc.ã¯2011幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ã¬ãããŠããã·ãã£ã«æ¬ç€Ÿã眮ããŠããŸãã